Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment

GBI Research’s report, “Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment” provides key data, information and analysis on the emerging countries diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories – Insulin Delivery (Insulin Pens, Traditional Insulin Pump Accessories, Insulin Pumps, Insulin Syringes) and Glucose Monitoring (Blood Glucose Test Strips, Blood Glucose Meters, Lancets).

The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape with key marketed products and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies covered include the China, India and Brazil.

- Market size data for two diabetes care devices market categories – Insulin Delivery (Insulin Pens, Traditional Insulin Pump Accessories, Insulin Pumps, Insulin Syringes) and Glucose Monitoring (Blood Glucose Test Strips, Blood Glucose Meters, Lancets).

- Annualized market revenues data, forecast forward for seven years to 2017. Company shares data for 2010.

- Qualitative analysis of key market trends for diabetes care devices imaging equipment in emerging countries market.

- Qualitative analysis of market drivers and restraints by each category within the diabetes care devices market.

- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market in emerging countries.

- Design and develop your product development, marketing and sales strategies in emerging countries.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline in emerging countries.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What’s the next big thing in the diabetes care devices market landscape – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market in emerging countries and the factors shaping it. SHOW LESS READ MORE >

1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 GBI Research Guidance

3 Disease Overview - Diabetes
3.1 Type 1 Diabetes
3.1.1 Introduction
3.1.2 Etiology, Disease Symptoms and Risk Factors
3.2 Type 2 Diabetes
3.2.1 Introduction
3.2.2 Etiology, Disease Symptoms and Risk Factors
3.2.3 Epidemiology

4 Diabetes Care Devices, Emerging Countries - Market Characterization
4.1 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2003–2010
4.2 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2010–2017
4.3 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Company Share (%), 2010
4.3.1 Diabetes Care Devices Market, China, Company Share (%), 2010
4.3.2 Diabetes Care Devices Market, India, Company Share (%), 2010
4.3.3 Diabetes Care Devices Market, Brazil, Company Share (%), 2010
4.4 Diabetes Care Devices, Emerging Countries: Market Dynamics
4.4.1 Market Drivers
4.4.2 Market Restraints

5 Diabetes Care Devices Market, Emerging Countries - Category Analysis
5.1 Insulin Delivery Devices - Overview
5.1.1 Insulin Pens
5.1.2 Traditional Insulin Pump Accessories
5.1.3 Traditional Insulin Pumps
5.1.4 Insulin Syringes
5.2 Insulin Delivery Devices Market, Emerging Countries, Revenue ($m), 2003–2017
5.2.1 Insulin Delivery Devices Market, China, Revenue ($m), 2003–2010
5.2.2 Insulin Delivery Devices Market, China, Revenue ($m), 2010–2017
5.2.3 Insulin Delivery Devices Market, India, Revenue ($m), 2003–2010
5.2.4 Insulin Delivery Devices Market, India, Revenue ($m), 2010–2017
5.2.5 Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003–2010
5.2.6 Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010–2017
5.3 Insulin Delivery Devices Market, Emerging Countries, Company Share (%), 2010
5.3.1 Insulin Delivery Devices Market, China, Company Share (%), 2010
5.3.2 Insulin Delivery Devices Market, India, Company Share (%), 2010
5.3.3 Insulin Delivery Devices Market, Brazil, Company Share (%), 2010
5.4 Insulin Delivery Devices, Emerging Countries, Market Dynamics
5.4.1 Market Drivers
5.4.2 Market Restraint
5.5 Glucose Monitoring Devices: Overview
5.5.1 Blood Glucose Meters
5.5.2 Blood Glucose Test Strips
5.5.3 Lancets
5.6 Glucose Monitoring Devices, Emerging Countries, Revenue ($m), 2003–2017
5.6.1 Glucose Monitoring Devices Market, China, Revenue ($m), 2003–2010
5.6.2 Glucose Monitoring Devices Market, China, Revenue ($m), 2010–2017
5.6.3 Glucose Monitoring Devices Market, India, Revenue ($m), 2003–2010
5.6.4 Glucose Monitoring Devices Market, India, Revenue ($m), 2010–2017
5.6.5 Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003–2010
5.6.6 Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010–2017
5.7 Glucose Monitoring Devices Market, Emerging Countries, Company Share (%), 2010
5.7.1 Glucose Monitoring Devices Market, China, Company Share (%), 2010
5.7.2 Glucose Monitoring Devices Market, India, Company Share (%), 2010
5.7.3 Glucose Monitoring Devices Market, Brazil, Company Share (%), 2010
5.8 Glucose Monitoring Devices, Emerging Countries, Market Dynamics
5.8.1 Market Drivers
5.8.2 Market Restraints

6 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil) - Competitive Assessment
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Overview
6.1.2 Marketed Products, Diabetes Care Devices
6.2 LifeScan, Inc. (Johnson & Johnson)
6.2.1 Overview
6.2.2 Marketed Products, Diabetes Care Devices
6.3 Novo Nordisk A/S
6.3.1 Overview
6.3.2 Marketed Products, Diabetes Care Devices
6.4 Medtronic, Inc.
6.4.1 Overview
6.4.2 Marketed Products, Diabetes Care Devices
6.5 Abbott Laboratories
6.5.1 Overview
6.5.2 Marketed Products, Diabetes Care Devices
6.6 Bayer HealthCare AG
6.6.1 Overview
6.6.2 Marketed Products, Diabetes Care Devices
6.7 Becton, Dickinson and Company
6.7.1 Overview
6.7.2 Marketed Products, Diabetes Care Devices
6.8 Sanofi
6.8.1 Overview
6.8.2 Marketed Products, Diabetes Care Devices
6.9 Eli Lilly and Company
6.9.1 Overview
6.9.2 Marketed Products, Diabetes Care Devices
6.10 Hindustan Syringes & Medical Devices Ltd.
6.10.1 Overview
6.10.2 Marketed Products, Diabetes Care Devices

7 Diabetes Care Devices, Emerging Countries (China, India, Brazil) - Pipeline Assessment
7.1 Diabetes Care Devices, Emerging Countries (China, India, Brazil), Pipeline Products Summary
7.1.1 MIT-P-I
7.1.2 Mylife OmniPod
7.1.3 V Pump
7.1.4 Patch Insulin Pump
7.1.5 Spring Hybrid Patch Pump
7.1.6 ClikSTAR
7.1.7 BGStar

8 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil) - Deals Analysis
8.1 Diabetes Care Devices Market, Mergers and Acquisitions, Emerging Countries (China, India, Brazil), 2007–2011
8.2 Key Deals, Diabetes Care Devices Market, 2007–2011
8.2.1 MicroPort Medical Acquires Beijing Pangerui Medical

9 Appendix
9.1 Definitions
9.1.1 Diabetes Care Devices
9.1.2 Glucose Monitoring
9.1.3 Blood Glucose Meters
9.1.4 Blood Glucose Test Strips
9.1.5 Lancets
9.1.6 Insulin Delivery
9.1.7 Insulin Pens
9.1.8 Insulin Pumps
9.1.9 Insulin Syringes
9.1.10 Traditional Insulin Pump Accessories
9.2 Acronyms
9.3 Sources
9.4 Research Methodology
9.5 Secondary Research
9.6 Primary Research
9.7 Models
9.8 Forecasts
9.9 Expert Panels
9.10 Contact Us
9.11 Disclaimer

1.1 List of Tables
Table 1: Diabetes Prevalence (%), Emerging Countries (China, India, Brazil), 2011
Table 2: Diabetes Care Devices, Emerging Countries (China, India, Brazil), Revenue ($m), 2003–2010
Table 3: Diabetes Care Devices, Emerging Countries (China, India, Brazil), Revenue ($m), 2010–2017
Table 4: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Company Revenue ($m), 2010
Table 5: Diabetes Care Devices Market, China, Company Revenue ($m), 2010
Table 6: Diabetes Care Devices Market, India, Company Revenue ($m), 2010
Table 7: Diabetes Care Devices Market, Brazil, Company Revenue ($m), 2010
Table 8: Diabetes Prevalence (%),Emerging Countries (China, India, Brazil), 2011
Table 9: List of Diabetes Awareness and Prevention Programs in Emerging Countries (China, India and Brazil), 2011
Table 10: Insulin Delivery Devices Market, China, Revenue ($m), 2003–2010
Table 11: Insulin Delivery Devices Market, China, Revenue ($m), 2010–2017
Table 12: Insulin Delivery Devices Market, India, Revenue ($m), 2003–2010
Table 13: Insulin Delivery Devices Market, India, Revenue ($m), 2010–2017
Table 14: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003–2010
Table 15: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010–2017
Table 16: Insulin Delivery Devices Market, China, Company Revenue ($m), 2010
Table 17: Insulin Delivery Devices Market, India, Company Revenue ($m), 2010
Table 18: Insulin Delivery Devices Market, Brazil, Company Revenue ($m), 2010
Table 19: Insulin Pens, Average Selling Price ($), 2010
Table 20: Incidence Rates of Type 1 Diabetes in Children, Emerging Countries, 2010
Table 21: Insulin Pumps, Average Selling Price, 2010
Table 22: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 & 2009
Table 23: Glucose Monitoring Devices Market, China, Revenue ($m), 2003–2010
Table 24: Glucose Monitoring Devices Market, China, Revenue ($m), 2010–2017
Table 25: Glucose Monitoring Devices Market, India, Revenue ($m), 2003–2010
Table 26: Glucose Monitoring Devices Market, India, Revenue ($m), 2010–2017
Table 27: Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003–2010
Table 28: Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010–2017
Table 29: Glucose Monitoring Devices Market, China, Company Revenue ($m), 2010
Table 30: Glucose Monitoring Devices Market, India, Company Revenue ($m), 2010
Table 31: Glucose Monitoring Devices Market, Brazil, Company Revenue ($m), 2010
Table 32: Key Hospital Groups Planning Expansion in Tier II and Tier III Regions in India, 2010
Table 33: F Hoffman-La Roche, Key Marketed Products, Emerging Countries
Table 34: LifeScan (Johnson & Johnson), Key Marketed Products, Emerging Countries
Table 35: Novo Nordisk, Key Marketed Products, Emerging Countries
Table 36: Medtronic, Key Marketed Products, Emerging Countries
Table 37: Abbott Laboratories, Key Marketed Products, Emerging Countries
Table 38: Bayer Healthcare, Key Marketed Products, Emerging Countries
Table 39: Becton, Dickinson and Company, Key Marketed Products, Emerging Countries
Table 40: Sanofi, Key Marketed Products, Emerging Countries
Table 41: Eli Lilly and Company, Key Marketed Products, Emerging Countries
Table 42: Hindustan Syringes & Medical Devices Ltd., Key Marketed Products, Emerging Countries
Table 43: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Pipeline Products Summary, 2011
Table 44: MIT-P-I, Product Status, 2011
Table 45: Mylife OmniPod, Product Status, 2011
Table 46: V Pump, Product Status, 2011
Table 47: Patch Insulin Pump, Product Status, 2011
Table 48: Spring Hybrid Patch Pump, Product Status, 2011
Table 49: ClikSTAR, Product Status, 2011
Table 50: BGStar, Product Status, 2011
Table 51: Diabetes Care Devices Market, Mergers and Acquisitions, Emerging Countries (China, India, Brazil), 2007–2011

1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation
Figure 2: Diabetes Prevalence (%), Emerging Countries (China, India, Brazil), 2011
Figure 3: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2003–2010
Figure 4: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2010–2017
Figure 5: Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Company Share (%), 2010
Figure 6: Diabetes Care Devices Market, China, Company Share (%), 2010
Figure 7: Diabetes Care Devices Market, India, Company Share (%), 2010
Figure 8: Diabetes Care Devices Market, Brazil, Company Share (%), 2010
Figure 9: Diabetes Care Devices, Emerging Countries (China, India, Brazil), Market Dynamics
Figure 10: Per Capita Expenditure on Healthcare, Emerging Countries (China, India, Brazil), 2005-2009
Figure 11: Insulin Delivery Devices, Market Segmentation, 2011
Figure 12: Insulin Delivery Devices Market, China, Revenue ($m), 2003– 2010
Figure 13: Insulin Delivery Devices Market, China, Revenue ($m), 2010–2017
Figure 14: Insulin Delivery Devices Market, India, Revenue ($m), 2003–2010
Figure 15: Insulin Delivery Devices Market, India, Revenue ($m), 2010–2017
Figure 16: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003–2010
Figure 17: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010–2017
Figure 18: Insulin Delivery Devices Market, China, Company Share (%), 2010
Figure 19: Insulin Delivery Devices Market, India, Company Share (%), 2010
Figure 20: Insulin Delivery Devices Market, Brazil, Company Share (%), 2010
Figure 21: Reasons for Type 1 Diabetes in Children
Figure 22: Glucose Monitoring Devices, Market Segmentation, 2011
Figure 23: Glucose Monitoring Devices Market, China, Revenue ($m), 2003–2010
Figure 24: Glucose Monitoring Devices Market, China, Revenue ($m), 2010–2017
Figure 25: Glucose Monitoring Devices Market, India, Revenue ($m), 2003–2010
Figure 26: Glucose Monitoring Devices Market, India, Revenue ($m), 2010–2017
Figure 27: Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003–2010
Figure 28: Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010–2017
Figure 29: Glucose Monitoring Devices Market, China, Company Share (%), 2010
Figure 30: Glucose Monitoring Devices Market, India, Company Share (%), 2010
Figure 31: Glucose Monitoring Devices Market, Brazil, Company Share (%), 2010
Figure 32: Diabetes Care Devices Market, China, Competitive Assessment, 2010
Figure 33: Diabetes Care Devices Market, India, Competitive Assessment, 2010
Figure 34: Diabetes Care Devices Market, Brazil, Competitive Assessment, 2010

- F. Hoffmann-La Roche Ltd.
- LifeScan, Inc. (Johnson & Johnson)
- Novo Nordisk A/S
- Medtronic, Inc.
- Abbott Laboratories
- Bayer HealthCare AG
- Becton, Dickinson and Company
- Sanofi
- Eli Lilly and Company
- Hindustan Syringes & Medical Devices Ltd.